QT Imaging Holdings (QTI)
NASDAQ:QTI
Want to see QTI full AI Analyst Report?
QTI Stock Chart & Stats
$5.95
--
Market closed
$5.95
--
Day’s Range― - ―
52-Week Range$2.16 - $9.21
Previous CloseN/A
VolumeN/A
Average Volume (3M)31.43K
Market Cap
$60.94M
Enterprise Value$135.61M
Total Cash (Recent Filing)$6.95M
Total Debt (Recent Filing)$5.80M
Price to Earnings (P/E)―
Beta-0.03
Next Earnings
Aug 06, 2026EPS Estimate
-0.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.96
Shares Outstanding12,042,500
10 Day Avg. Volume22,708
30 Day Avg. Volume31,432
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)9.92
Price to Sales (P/S)3.38
P/FCF Ratio-7.04
Enterprise Value/Market Cap2.23
Enterprise Value/Revenue5.99
Enterprise Value/Gross Profit14.36
Enterprise Value/Ebitda-24.09
Forecast
1Y Price Target
$10.00Price Target Upside68.07% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.11
Revenue Forecast (FY)$38.65M
Bulls Say, Bears Say
Bulls Say
Rapid Revenue And Unit Shipment GrowthSustained double‑digit revenue growth and rising unit shipments indicate real market adoption of the imaging platform. Scaling unit sales improves fixed cost absorption and creates a basis for recurring service and software revenue, supporting a durable path to operating leverage if growth persists.
Multi‑year Distributor Commitments And BacklogSigned multi‑year minimum orders provide predictable revenue visibility and reduce short‑term demand risk, enabling production planning and prioritization of commercial rollout. Committed channel demand is a durable commercial asset that supports scaling and can underpin financing and inventory decisions.
Regulatory, Reimbursement And Product AdvancementsRegulatory clearances and an AMA CPT code materially improve reimbursement pathways and market access, while software and imaging improvements enhance clinical utility. These structural milestones increase adoption durability, make installations stickier, and support long‑term revenue per unit via software/services.
Bears Say
Sustained Negative Cash Flow And Limited RunwayOngoing negative operating and free cash flow with modest cash on hand means the company remains reliant on external funding to execute its commercial plan. This structural cash shortfall creates execution risk for multi‑month initiatives and can force dilutive financing or constrained spending absent sustained margin improvement or sequencing.
Deep Losses And Negative MarginsDespite revenue scale‑up, entrenched negative margins and recurring GAAP losses indicate the business has not reached self‑funding operational profitability. Persistent losses limit reinvestment capacity, raise reliance on capital markets, and mean strategy depends on sustained top‑line growth and margin recovery to become durable.
Leverage And Rising Financing CostsMaterial leverage for a loss‑making company increases fixed financing obligations and reduces balance sheet flexibility. Higher interest rates raise cash interest expense and magnify refinancing or covenant risks, making the capital structure sensitive to execution slippage and potentially increasing dilution if new equity is required.
QT Imaging Holdings News
QTI FAQ
What was QT Imaging Holdings’s price range in the past 12 months?
QT Imaging Holdings lowest stock price was $2.16 and its highest was $9.21 in the past 12 months.
What is QT Imaging Holdings’s market cap?
QT Imaging Holdings’s market cap is $60.94M.
When is QT Imaging Holdings’s upcoming earnings report date?
QT Imaging Holdings’s upcoming earnings report date is Aug 06, 2026 which is in 76 days.
How were QT Imaging Holdings’s earnings last quarter?
QT Imaging Holdings released its earnings results on May 13, 2026. The company reported -$0.25 earnings per share for the quarter, missing the consensus estimate of -$0.135 by -$0.115.
Is QT Imaging Holdings overvalued?
According to Wall Street analysts QT Imaging Holdings’s price is currently Undervalued.
Does QT Imaging Holdings pay dividends?
QT Imaging Holdings does not currently pay dividends.
What is QT Imaging Holdings’s EPS estimate?
QT Imaging Holdings’s EPS estimate is -0.22.
How many shares outstanding does QT Imaging Holdings have?
QT Imaging Holdings has 12,042,500 shares outstanding.
What happened to QT Imaging Holdings’s price movement after its last earnings report?
QT Imaging Holdings reported an EPS of -$0.25 in its last earnings report, missing expectations of -$0.135. Following the earnings report the stock price went down -16.733%.
Which hedge fund is a major shareholder of QT Imaging Holdings?
Currently, no hedge funds are holding shares in QTI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
QT Imaging Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.00 (68.07% Upside)
$10.00 (68.07% Upside)
Hedge Fund Trend
Decreased
By 66.1K Shares
Last Quarter.
Last Quarter.
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
274.13%
12-Months-Change
Fundamentals
Return on Equity
-6330.64%
Trailing 12-Months
Asset Growth
102.75%
Trailing 12-Months
Company Description
QT Imaging Holdings
QT Imaging Holdings, Inc. engages in the manufacturing, research, and development of automated breast imaging system for producing high-resolution transmission ultrasound images. It offers QT Ultrasound Breast Scanner that provides reflection-mode and transmission-mode images of a patient's breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.
QTI Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed meaningful commercial, regulatory and clinical progress — including 133% year-over-year revenue growth, shipment increases, substantial multi-year distributor contracts, new CPT code approval, FDA enhancements clearance, UAE clearance, product/software advancements and improved GAAP loss and EBITDA trends. However, the company also faces margin compression (gross margin down from 65% to 41%), higher operating expenses and adjusted EBITDA weakness, modest cash on hand ($7.0M) versus ongoing quarterly cash burn (~$3.7M), and higher borrowing costs following a loan interest rate increase to 12%. Regulatory timing (e.g., SFDA) and geopolitical shipping disruptions also present execution risks. On balance, the positive commercial momentum, validated clinical data and significant distribution commitments outweigh near-term financial and operational headwinds, though execution on margin improvement, cash management and international approvals will be important to realize guidance.View all QTI earnings summariesQTI Stock 12 Month Forecast
Average Price Target
$10.00
▲(68.07% Upside)
Technical Analysis
Ownership Overview
16.50% Insiders
0.02% Mutual Funds
17.16% Other Institutional Investors
66.15% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---